Evogene Announces Pricing Of $8.5M Registered Direct Offering Of 8.5M Shares At Purchase Price Of $1/Share
Portfolio Pulse from Benzinga Newsdesk
Evogene has announced the pricing of its $8.5M registered direct offering of 8.5M shares at a purchase price of $1 per share.
July 17, 2023 | 12:16 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Evogene's direct offering of 8.5M shares at $1 per share could dilute existing shareholders' equity.
The direct offering of 8.5M shares at $1 per share by Evogene could lead to dilution of existing shareholders' equity. This could potentially lead to a decrease in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100